Lanean...
Biological therapies for atrial fibrillation: ready for prime time?
Atrial fibrillation is a prominent cause of morbidity and mortality in developed countries. Treatment strategies center on controlling atrial rhythm or ventricular rate. The need for anticoagulation is an independent decision from the rate vs. rhythm control debate. This review discusses novel biolo...
Gorde:
| Argitaratua izan da: | J Cardiovasc Pharmacol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879872/ https://ncbi.nlm.nih.gov/pubmed/26222989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000293 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|